The Center for Interdisciplinary Research on AIDS at Yale University (CIRA) has selected Dr. Sunil Parikh, Yale Schools of Public Health and Medicine; Dr. Jennifer Sherr, Yale School of Medicine; and Dr. Roman Ivasiy, Yale School of Medicine, as recipients of the 2025 CIRA Pilot Projects in HIV Research Program, including the CIRA-Yale Institute for Global Health Joint Pilot Award. The awards provide funding for preliminary and feasibility studies that will lead to larger evaluations of novel interventions or implementation strategies. The CIRA-YIGH Joint Pilot Award specifically supports research addressing the syndemics of HIV/AIDS and non-communicable diseases (NCDs).
- February 14, 2025Source: NBC CT
Dr. Sherr discusses childhood diabetes.
- February 12, 2025Source: WTNH
Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.
- January 14, 2025Source: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
- January 14, 2025Source: YouTube/The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
- November 22, 2024Source: Yahoo
NEW HAVEN, Conn. (WTNH) In today's health headlines, can GLP-1 drugs reverse prediabetes? Plus, how to reduce food noise and stick to weight loss goals during Thanksgiving week. Dr. Ania Jastreboff, Yale Medicine endocrinologist and obesity medicine physician-scientist and director of the Yale Obesity Research Center at Yale School of Medicine, discussed these topics.
- November 18, 2024Source: Health Day
MONDAY, Nov. 18, 2024 (HealthDay News) -- For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio
- November 05, 2024
Yale faculty, trainees, postdocs, and students will present research at the upcoming American Heart Association Scientific Sessions in Chicago later this month.
- September 19, 2024Source: Yale Insights
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology) at Yale School of Medicine, discusses the range of diseases treated by novel weight-loss drugs such as Ozempic, Mounjaro, and Wegovy.
- August 12, 2024Source: DIAtribe
A revolution is underway in diabetes technology and treatments, and potentially groundbreaking new advances toward a cure are coming into focus. But people with diabetes know that staying healthy while juggling the demands of everyday life is hard work. Amid the hopeful future and breakneck pace of new discoveries, how can people with diabetes get the care and support they need?